Xcout Intel
Harpoon Therapeutics, Inc.
Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company headquartered in South San Francisco, California. It specializes in developing novel T-cell engaging therapies for the treatment of cancer.
Subscribe to see Harpoon Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Harpoon Therapeutics, Inc. at a glance
Harpoon Therapeutics, Inc. is a drug discovery company headquartered in United States. Its most recent funding round raised $100.2M in October 2023. Xcout tracks 1 named person at Harpoon Therapeutics, Inc., including Rob Davis (Chairman of the Board and Chief Executive Officer).
Harpoon Therapeutics, Inc. leadership
- Rob DavisChairman of the Board and Chief Executive Officer
Harpoon Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $100.2M | — | |
| SEC Form D filing | $25M | — | |
| Series C | $70M | — | |
| SEC Form D filing | $25.2M | — | |
| Series B | $45M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Harpoon Therapeutics, Inc. competitors
A few of Harpoon Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Arch Oncology is a clinical-stage immuno-oncology company headquartered in Brisbane, California, with an additional scientific research laboratory in St. Louis, Missouri. The company develops antibody-based cancer therapies.
BobcatBio, Inc. is a clinical-stage biotechnology company founded in 2020 and headquartered in Hummelstown, Pennsylvania. The company focuses on developing macrophage-based cell therapies and cancer-specific immunotherapies, including its lead cellular therapy candidate RB-1355, for the treatment of solid tumors.
Nura Bio Inc. is a privately held biopharmaceutical company headquartered in South San Francisco, California, founded in 2018 to develop novel treatments for neurological diseases.
Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Boston, Massachusetts. The company discovers and develops Anticalin-based drugs designed to address significant medical needs.
Promontory Therapeutics Inc. is a privately held, clinical-stage pharmaceutical company founded in 2010 and headquartered in New York, NY. The firm focuses on small molecule immunotherapy.
Amunix Pharmaceuticals, Inc. is a biopharmaceutical company located in South San Francisco and Mountain View, California. The company focuses on oncology, leveraging its proprietary Pro-XTEN technology platform to engineer novel protein therapeutics.
Get Harpoon Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Harpoon Therapeutics, Inc. in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access